Chronix ASCO 2017: Dr Tomislav Dragovich
Experts on Chronix Biomedical CNI Monitor test. Testing for drug efficacy. #TheTurningPointInCancerFight
Predicting Treatment Outcomes in Immunotherapy
Weiss, G. et al. Tumor Cell-Free DNA Copy Number Instability Predicts Therapeutic Response to Immunotherapy.
Genomic analysis of tissue malignancies is well recapitulated by tumor cell free DNA (cfDNA) using the power of Next Generation Sequencing (NGS).
Cohort Study in LiverTx
Schütz E. et al. Graft-Derived Cell-Free DNA – a Noninvasive Early Rejection and Graft Damage Marker in Liver Transplantation PlosMed (2017;) doi:10.1371/journal.pmed.1002286
Graft-derived cell-free DNA (GcfDNA), which is released into the blood stream by necrotic and apoptotic cells, is a promising noninvasive organ integrity biomarker.
Digital PCR of cfDNA for Transplant Rejetion
Beck J. et alDigital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury. Clin Chem. 2013 ;59:1732-41
Cell-free DNA (cfDNA) from grafts in the circulation of transplant recipients is a potential biomarker of rejection. Its usefulness was investigated after heart transplantation during the maintenance phase by use of microarrays and massive parallel sequencing of donor and recipient DNA.
Using circulating cell-free DNA to monitor personalized cancer therapy
High-quality genomic analysis is critical for personalized pharmacotherapy in patients with cancer
Chronix Biomedical is pleased to announce that results of a clinical trial of its liquid biopsy test have been accepted for presentation at the ASCO Annual Meeting.
Chronix Biomedical
The poster presentation will cover results of a study evaluating the Copy Number Instability (CNI) score as a prognostic test in head and neck cancer.
Chronix Biomedical Study Demonstrates Its Blood Test Can Predict Response to Cancer Immunotherapy
Chronix Biomedical
First study of a liquid biopsy to predict response to immunotherapy...
Chronix Biomedical provides update on studies and presentations
Chronix Biomedical
Data from pilot studies using Chronix’s CNI test submitted for presentation at a high profile scientific meeting...
10 Cancer Symptoms
Chronix Biomedical
The best way to fight cancer is to diagnose it in its early stage...
WORLD CANCER DAY
Chronix Biomedical
World Cancer Day is a perfect opportunity to focus on your health state...